Kaolin is a layered silicate mineral. Kaolin is used in ceramics, medicine, coated paper, as a food additive, in toothpaste, as a light diffusing material in white incandescent light bulbs, and in cosmetics. Until the early 1990s it was the active substance of anti-diarrhoea medicine Kaopectate.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Digoxin | The serum concentration of Digoxin can be decreased when it is combined with Kaolin. |
| Acetyldigitoxin | The serum concentration of Acetyldigitoxin can be decreased when it is combined with Kaolin. |
| Deslanoside | The serum concentration of Deslanoside can be decreased when it is combined with Kaolin. |
| Ouabain | The serum concentration of Ouabain can be decreased when it is combined with Kaolin. |
| Digitoxin | The serum concentration of Digitoxin can be decreased when it is combined with Kaolin. |
| Oleandrin | The serum concentration of Oleandrin can be decreased when it is combined with Kaolin. |
| Cymarin | The serum concentration of Cymarin can be decreased when it is combined with Kaolin. |
| Proscillaridin | The serum concentration of Proscillaridin can be decreased when it is combined with Kaolin. |
| Metildigoxin | The serum concentration of Metildigoxin can be decreased when it is combined with Kaolin. |
| Lanatoside C | The serum concentration of Lanatoside C can be decreased when it is combined with Kaolin. |
| Gitoformate | The serum concentration of Gitoformate can be decreased when it is combined with Kaolin. |
| Acetyldigoxin | The serum concentration of Acetyldigoxin can be decreased when it is combined with Kaolin. |
| Peruvoside | The serum concentration of Peruvoside can be decreased when it is combined with Kaolin. |
| Chloroquine | Kaolin can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Eltrombopag | Kaolin can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Raltegravir | Kaolin can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Quinidine | Kaolin can cause a decrease in the absorption of Quinidine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Clindamycin | Kaolin can cause a decrease in the absorption of Clindamycin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Lincomycin | Kaolin can cause a decrease in the absorption of Lincomycin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Pirlimycin | Kaolin can cause a decrease in the absorption of Pirlimycin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Deferasirox | Kaolin can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Dolutegravir | The serum concentration of Dolutegravir can be decreased when it is combined with Kaolin. |
| Halofantrine | Kaolin can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Ursodeoxycholic acid | Kaolin can cause a decrease in the absorption of Ursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Glycochenodeoxycholic Acid | Kaolin can cause a decrease in the absorption of Glycochenodeoxycholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Cholic Acid | Kaolin can cause a decrease in the absorption of Cholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Glycocholic acid | Kaolin can cause a decrease in the absorption of Glycocholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Deoxycholic acid | Kaolin can cause a decrease in the absorption of Deoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Taurocholic acid | Kaolin can cause a decrease in the absorption of Taurocholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Obeticholic acid | Kaolin can cause a decrease in the absorption of Obeticholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Chenodeoxycholic acid | Kaolin can cause a decrease in the absorption of Chenodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Taurochenodeoxycholic acid | Kaolin can cause a decrease in the absorption of Taurochenodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Tauroursodeoxycholic acid | Kaolin can cause a decrease in the absorption of Tauroursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Bamet-UD2 | Kaolin can cause a decrease in the absorption of Bamet-UD2 resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| cis-Diamminechlorocholylglycinateplatinum(II) | The serum concentration of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when it is combined with Kaolin. |
| Dehydrocholic acid | Kaolin can cause a decrease in the absorption of Dehydrocholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Hyodeoxycholic Acid | Kaolin can cause a decrease in the absorption of Hyodeoxycholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Aramchol | The serum concentration of Aramchol can be decreased when it is combined with Kaolin. |
| Ox bile extract | The serum concentration of Ox bile extract can be decreased when it is combined with Kaolin. |
| Technetium Tc-99m oxidronate | The serum concentration of Technetium Tc-99m oxidronate can be increased when it is combined with Kaolin. |
| Phenytoin | Kaolin can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Mephenytoin | Kaolin can cause a decrease in the absorption of Mephenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Carbamazepine | Kaolin can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Methylphenobarbital | Kaolin can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Phenobarbital | Kaolin can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Hydroxychloroquine | Kaolin can cause a decrease in the absorption of Hydroxychloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Roxadustat | Kaolin can cause a decrease in the absorption of Roxadustat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Vadadustat | The serum concentration of Vadadustat can be decreased when it is combined with Kaolin. |